# A Study of Drug-Drug Interaction Between Danoprevir Coadministered With Low-Dose Ritonavir and Tenofovir Disoproxil Fumarate or Atazanavir

> **NCT01592305** · PHASE1 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 40 (actual)

## Conditions studied

- Healthy Volunteer

## Interventions

- **DRUG:** atazanavir
- **DRUG:** danoprevir
- **DRUG:** ritonavir
- **DRUG:** tenofovir disoproxil fumarate

## Key facts

- **NCT ID:** NCT01592305
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-05
- **Primary completion:** 2012-06
- **Final completion:** 2012-06
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2016-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01592305

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01592305, "A Study of Drug-Drug Interaction Between Danoprevir Coadministered With Low-Dose Ritonavir and Tenofovir Disoproxil Fumarate or Atazanavir". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01592305. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*